EFA - ETF AI Analysis

Top Page

iShares MSCI EAFE ETF (EFA)

Rating:66Neutral

Price Target:―

EFA, the iShares MSCI EAFE ETF, has a solid overall rating driven by high-quality global leaders like Novartis, AstraZeneca, HSBC, and Toyota, which all show strong financial health, positive earnings commentary, and generally supportive valuations or momentum. These strengths are balanced by some holdings with valuation or technical concerns, such as Roche and SAP, which may be overvalued or facing weaker price trends. The main risk factor is that many top positions are concentrated in a few major non-U.S. sectors and regions, so shifts in those markets or in global sentiment toward large international stocks could meaningfully affect the fund.

Positive Factors

Broad International Diversification

The fund spreads its investments across many developed countries like Japan, the UK, France, and Germany, which helps reduce the impact of problems in any single market.

Strong Contribution from Key Holdings

Several of the largest positions, such as ASML, Roche, Novartis, Siemens, Toyota, and HSBC, have shown solid gains this year, supporting the ETF’s overall performance.

Balanced Sector Mix

Holdings are spread across financials, industrials, health care, technology, and other sectors, which can help smooth returns when one industry is struggling.

Negative Factors

Meaningful Exposure to Lagging Stocks

Some top holdings like Nestlé, SAP, AstraZeneca, and Shell have been weak this year, which can drag on the fund’s results if the trend continues.

Heavy Tilt Toward Financials and Industrials

A large share of the portfolio is in financial and industrial companies, so a downturn in these sectors could hurt the ETF more than a more evenly balanced fund.

Moderate Expense Ratio

The fund’s fees are not especially low for a large, broad international ETF, which slightly reduces the net return investors keep over time.

EFA vs. SPDR S&P 500 ETF (SPY)

AUM74.73B

RegionDeveloped Markets

Expense Ratio0.32%

Beta0.72

IssueriShares

Inception DateAug 14, 2001

Dividend Yield3.27%

Asset ClassEquity

Index TrackedMSCI EAFE

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume28,197,835

30 Day Avg. Volume22,082,797

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

111.90

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering683

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

EFA Summary

The iShares MSCI EAFE ETF (EFA) is a fund that follows the MSCI EAFE Index, which tracks stocks from developed countries outside the U.S. and Canada, such as Japan, the UK, and Europe. It owns many large, well-known companies like Toyota, Nestlé, and AstraZeneca across sectors including financials, industrials, and healthcare. Someone might invest in EFA to diversify their portfolio internationally and reduce reliance on the U.S. market while seeking long-term growth from established global economies. A key risk is that its value can rise or fall with international stock markets and currency movements.

How much will it cost me?The iShares MSCI EAFE ETF (EFA) has an expense ratio of 0.32%, meaning you’ll pay $3.20 per year for every $1,000 invested. This cost is slightly higher than average for passively managed ETFs because it provides broad exposure to developed international markets, which can involve higher operational costs compared to U.S.-focused funds.

What would affect this ETF?The iShares MSCI EAFE ETF could benefit from economic recovery in developed markets outside North America, particularly in Europe and Asia, as well as growth in sectors like financials and technology, which are heavily represented in its holdings. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance, especially in sectors like financials and energy. Diversification across industries and countries provides some resilience, but global economic uncertainty remains a key risk.

EFA Top 10 Holdings

EFA’s story right now is powered by a handful of global heavyweights, with Europe and Japan firmly in the driver’s seat. ASML is the clear star, rising strongly and giving the fund a tech edge despite its relatively small sector weight. A trio of pharma giants—Roche, AstraZeneca, and Novartis—are also climbing steadily, turning health care into a quiet engine of returns. Financials like HSBC and Mitsubishi UFJ are adding support rather than drama, while Siemens is more mixed, occasionally tapping the brakes on otherwise solid developed-markets performance.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	2.52%	$1.88B	€453.03B	81.53%	76 Outperform
ROG	Roche Holding AG	1.51%	$1.12B	CHF281.05B	31.30%	73 Outperform
NOVN	Novartis AG	1.46%	$1.09B	CHF237.56B	25.48%	80 Outperform
AZN	AstraZeneca	1.46%	$1.09B	$306.32B	22.83%	80 Outperform
HSBA	HSBC Holdings	1.38%	$1.03B	£219.64B	45.15%	80 Outperform
NESN	Nestlé SA	1.24%	$922.93M	CHF202.69B	2.26%	71 Outperform
SHEL	Shell (UK)	1.09%	$811.18M	£175.14B	22.70%	73 Outperform
7203	Toyota Motor	1.03%	$772.24M	¥45.37T	22.61%	80 Outperform
SIE	Siemens	0.96%	$716.57M	€171.36B	-3.90%	74 Outperform
CBA	Commonwealth Bank of Australia	0.95%	$709.98M	AU$288.65B	12.42%	64 Neutral

EFA Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

100.74

Negative

100DMA

96.94

Positive

200DMA

92.77

Positive

Market Momentum

MACD

0.24

Positive

RSI

37.19

Neutral

STOCH

30.04

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFA, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 103.58, equal to the 50-day MA of 100.74, and equal to the 200-day MA of 92.77, indicating a neutral trend. The MACD of 0.24 indicates Positive momentum. The RSI at 37.19 is Neutral, neither overbought nor oversold. The STOCH value of 30.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EFA.

EFA Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
EFA	―	―	$74.73B	0.32%	66 Neutral
IEFA	―	―	$179.59B	0.07%	65 Neutral
EFV	―	―	$30.86B	0.33%	67 Neutral
SCZ	―	―	$14.42B	0.40%	58 Neutral
ESGD	―	―	$11.47B	0.20%	60 Neutral
JIRE	―	―	$10.10B	0.24%	68 Neutral

Performance Comparison

EFA

iShares MSCI EAFE ETF

99.16

17.64

21.64%

IEFA

iShares Core MSCI EAFE ETF

―

EFV

iShares MSCI EAFE Value ETF

―

SCZ

iShares MSCI EAFE Small-Cap ETF

―

ESGD

iShares ESG Aware MSCI EAFE ETF

―

JIRE

JPMorgan International Research Enhanced Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents